SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-093619
Filing Date
2015-03-16
Accepted
2015-03-16 16:05:41
Documents
5
Period of Report
2015-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d890335d8k.htm 8-K 23381
2 EX-2.1 d890335dex21.htm EX-2.1 18547
3 EX-23.1 d890335dex231.htm EX-23.1 4908
4 EX-99.1 d890335dex991.htm EX-99.1 590961
5 EX-99.2 d890335dex992.htm EX-99.2 391090
  Complete submission text file 0001193125-15-093619.txt   1030268
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15702913
SIC: 2834 Pharmaceutical Preparations